12:13 PM EST - The Yield Growth Corp. : Announced that it has entered into a distribution and licensing agreement dated August 25, 2019 with 2699598 Ontario Corp. DBA Melorganics Hellas for European rights to six product formulas for CBD infusion for a fee of $900,000. Yield has agreed to license to Melorganics in perpetuity the non exclusive rights to formulas and know-how to manufacture and distribute CBD foot cream, CBD body oil, CBD muscle relief balm, CBD body exfoliant, CBD relief gel and CBD hand cream. The formulas may be developed by Melorganics into products infused with CBD and other cannabinoids and distributed throughout the European Union under one brand to be developed by Melorganics (the "Brand"). Yield shall have approval on the Brand and packaging of the products. The $900,000 fee is due within one week and may be paid by the issuance of Melorganics Units to Yield. Upon being issued Melorganics Units, Yield shall own approximately 18% of Melorganics and shall have the right to appoint a Director to the Board of Directors of Melorganics. The value of the Melorganics Units are based on the most recent private placement into Melorganics. The Yield Growth Corp.
shares BOSS:CNX are trading unchanged at $0.31.
